DnB Asset Management
UTHR icon

DnB Asset Management’s United Therapeutics UTHR Stock Holding History

DnB Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Hold
8,646
– – 0.01% 497
2026
Q1 		$5.13M Buy
8,646
+163
+2% +$81.2K 0.02% 435
2025
Q4 		$4.13M Buy
8,483
+977
+13% +$455K 0.01% 484
2025
Q3 		$3.15M Sell
7,506
-58
-0.8% -$19.5K 0.01% 517
2025
Q2 		$2.17M Sell
7,564
-472
-6% -$141K 0.01% 555
2025
Q1 		$2.48M Buy
8,036
+438
+6% +$150K 0.01% 531
2024
Q4 		$2.68M Sell
7,598
-207
-3% -$76.1K 0.01% 528
2024
Q3 		$2.8M Buy
7,805
+5
+0.1% +$1.69K 0.01% 515
2024
Q2 		$2.48M Buy
7,800
+1,208
+18% +$320K 0.01% 507
2024
Q1 		$1.51M Sell
6,592
-3,786
-36% -$854K 0.01% 588
2023
Q4 		$2.28M Sell
10,378
-4,409
-30% -$1.02M 0.01% 522
2023
Q3 		$3.34M Buy
+14,787
New +$3.41M 0.02% 439
2020
Q3 		– Sell
-93,555
Closed -$11.3M – 620
2020
Q2 		$11.3M Sell
93,555
-43,135
-32% -$4.85M 0.13% 126
2020
Q1 		$13M Buy
136,690
+17,954
+15% +$1.71M 0.19% 104
2019
Q4 		$10.5M Buy
+118,736
New +$10.4M 0.1% 159
2019
Q2 		– Sell
-25,243
Closed -$2.96M – 642
2019
Q1 		$2.96M Buy
25,243
+9,487
+60% +$1.11M 0.03% 321
2018
Q4 		$1.72M Buy
+15,756
New +$1.83M 0.02% 420

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DnB Asset Management's UTHR Position: Q2 2026 in Review

DnB Asset Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 8,646 shares worth $4.68M. The position accounts for 0.01% of the portfolio, ranked #497.

DnB Asset Management first reported a position in UTHR in Q4 2018 and has held it in 17 quarters since. The position peaked at $13M in Q1 2020. 647 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • DnB Asset Management held 8,646 shares of United Therapeutics worth $4.68M as of Q2 2026.
  • DnB Asset Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of DnB Asset Management's portfolio in Q2 2026, its #497 holding.
  • DnB Asset Management first reported a position in United Therapeutics in Q4 2018 and has held it in 17 quarters since.
  • DnB Asset Management's United Therapeutics position peaked at $13M in Q1 2020.
  • 647 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.